In particular, we explored the effects of PF on improving fatty liver and IR in NAFLD rats based on its effects on the lipid metabolism-associated regulators and insulin-associated IRS/Akt/GSK3β pathway. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.